2021
DOI: 10.23938/assn.0965
|View full text |Cite
|
Sign up to set email alerts
|

Safety considerations during prescription of non-steroidal anti-inflammatory drugs (NSAIDs), through a review of systematic reviews

Abstract: Safety considerations during prescription of non-steroidal antiinflammatory drugs (NSAIDs), through a review of systematic reviews Consideraciones de seguridad en la prescripción de medicamentos antiinflamatorios no esteroideos (AINEs), a través de una revisión de revisiones sistemáticas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 40 publications
0
7
0
1
Order By: Relevance
“…Despite their widespread use, long-term exposure to NSAIDs can lead to serious cardiovascular events such as myocardial infarction and stroke, as well as gastrointestinal damage, including bleeding, ulceration, and perforation, which can be fatal. Additionally, kidney injury, hepatotoxicity, and other relatively minor adverse effects may occur [ 46 ].…”
Section: Galactose For Drug Deliverymentioning
confidence: 99%
“…Despite their widespread use, long-term exposure to NSAIDs can lead to serious cardiovascular events such as myocardial infarction and stroke, as well as gastrointestinal damage, including bleeding, ulceration, and perforation, which can be fatal. Additionally, kidney injury, hepatotoxicity, and other relatively minor adverse effects may occur [ 46 ].…”
Section: Galactose For Drug Deliverymentioning
confidence: 99%
“…The top five causes of hospital admissions include serious complications related to the use of these drugs [ 25 ]. This is especially true for over-the-counter drugs from the group of Non-steroidal anti-inflammatory drugs (NSAIDs) [ 13 ], which are responsible for approximately 25% of all drug-related complications [ 10 , 26 , 27 , 28 ].…”
Section: Health Risks Associated With the Use Of Otc Medicinesmentioning
confidence: 99%
“…The reason is the alarmingly growing number of poisonings related to paracetamol use, among others [ 14 , 29 , 30 ]. Poland is negatively distinguished by, among other things, no limitation in the number of drug packages or doses sold outside pharmacies, especially non-steroidal anti-inflammatory drugs and paracetamol [ 7 , 12 , 28 , 29 , 31 ]. Requirements for the composition, pharmaceutical form, strength, and content of the active substances in the packaging of a medicinal product or the packaging size of a medicinal product for medicinal products that may be authorized for non-pharmacy marketing are specified in annexes 2 and 3 to the regulation of the minister of health of 21 December 2021 on the list of medicinal products which may be admitted to trading in non-pharmacy outlets and pharmacy outlets, and the criteria for classifying these products to individual lists [ 10 , 11 ].…”
Section: Health Risks Associated With the Use Of Otc Medicinesmentioning
confidence: 99%
“…Following this classification, extensive research conducted for the synthesis of selective COX-2 inhibitors and several drugs including celecoxib and rofecoxib were marketed [ 4 , 5 ]. Compared to traditional NSAIDs, these drugs had fewer gastrointestinal side effects [ 6 8 ], but after a short time, it was reported that they caused cardiovascular side effects such as thrombosis, myocardial infarction, and cardiac dysfunction [ 9 13 ]. The proposed mechanism for these effects is the inhibition of prostacyclin production in vessels which mediate platelet activation and atherogenesis [ 14 ].…”
Section: Introductionmentioning
confidence: 99%